ReviewCancers2022

The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients.

Anna Pawłowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.